Effect of Oxygen in Normoxaemic COPD Patients Who Desaturate During Exercise
Effect of Ambulatory Oxygen in Normoxaemic COPD Patients Who Desaturate During Exercise. A Randomised Placebo Controlled Trial of Patients Who Participate in Pulmonary Rehabilitation
1 other identifier
interventional
45
1 country
1
Brief Summary
In COPD patients with desaturation during exercise, several studies have shown an acute beneficial effect of supplemental oxygen. Therefore, both the British Thoracic Society and the American Thoracic Society guidelines recommend supplemental oxygen to patients who desaturate \>4% and to below 88-90%. However, long-term studies have not been able to support this intervention. In this study of COPD patients, who desaturate and participate in a 7-week pulmonary rehabilitation programme, we examine the effect of supplemental oxygen on exercise tolerance, health status, and exacerbation rates. In a randomised design patients trained either with room air or with 2 litres oxygen per minute from a portable oxygen concentrator. All patients were asked to exercise every day for 30 minutes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started May 2007
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 31, 2007
CompletedFirst Posted
Study publicly available on registry
January 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedMarch 22, 2012
March 1, 2012
4.6 years
December 31, 2007
March 21, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Shuttle walk (endurance time)
7 week, 3 and 6 months
Secondary Outcomes (5)
St. George Respiratory Questionnaire
7 week, 3 and 6 months
Usage of oxygen concentrator (Spent time according to the meter)
7 weeks, 3 and 6 months
Exacerbations requiring medical treatment (prednisolone or antibiotics)
7 weeks, 3 and 6 months
Hospitalisation
7 weeks, 3 and 6 months
Mortality
7 weeks, 3 and 6 months
Study Arms (2)
2
NO INTERVENTIONRehabilitation, no supplemental oxygen
1
EXPERIMENTALRehabilitation plus supplemental oxygen
Interventions
Eligibility Criteria
You may qualify if:
- COPD
- participate in a 7-weeks pulmonary rehabilitation programme
- desaturate \>4% to less than 90% during endurance shuttle walk test
You may not qualify if:
- long-term oxygen therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hvidovre University Hospitallead
- Danish Lung Associationcollaborator
Study Sites (1)
University Hospital, Hvidovre, Cardio-pulmonary depart.
Hvidovre, 2650, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas J Ringbaek, doctor
Hvidovre Hospital, University hospital, Cardio-pulmonary depart.
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Consultant
Study Record Dates
First Submitted
December 31, 2007
First Posted
January 11, 2008
Study Start
May 1, 2007
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
March 22, 2012
Record last verified: 2012-03